Independent analyst Kunal Bothra has a buy call on Lupin Ltd.
with a target price of Rs 805.
The current price of Lupin Ltd.
is Rs 766.25 Time period given by the analyst is Intra Day when Lupin Ltd.
price can reach defined target.Kunal Bothra recommended to keep a stoploss at Rs 750 .
Lupin Ltd.
key Products/Revenue Segments include Pharmaceuticals which contributed Rs 10657.32 Crore to Sales Value (93.84 % of Total Sales), Other Services which contributed Rs 374.24 Crore to Sales Value (3.29 % of Total Sales), Export Incentives which contributed Rs 250.66 Crore to Sales Value (2.20 % of Total Sales) and Other Operating Revenue which contributed Rs 74.10 Crore to Sales Value (0.65 % of Total Sales)for the year ending 31-Mar-2019.
For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 4296.90 Crore, down -1.35 % from last quarter Sales of Rs 4355.83 Crore and up 10.43 % from last year same quarter Sales of Rs 3890.93 Crore Company has reported net profit after tax of Rs -124.40 Crore in latest quarter.
The companys top management includes Dr.K U Mada, Dr.Kamal K Sharma, Mr.Dileep C Choksi, Mr.Jean-Luc Belingard, Mr.Nilesh Deshbandhu Gupta, Mr.R A Shah, Mr.Richard Zahn, Mrs.Manju D Gupta, Ms.Christine Mundkur, Ms.Vinita Gupta.
Company has B S R - Co.
LLP as its auditors.
As on 31-12-2019, the company has a total of 452,906,754 shares outstanding.